Volume 28, Issue 8 pp. 790-796
Research Article
Full Access

Epistatic interactions with a common hypomorphic RET allele in syndromic Hirschsprung disease

L. de Pontual

L. de Pontual

Université Paris-René Descartes, Faculté de Médecine, INSERM U-781, AP-HP, Hôpital Necker-Enfant Malades, Paris, France

Search for more papers by this author
A. Pelet

A. Pelet

Université Paris-René Descartes, Faculté de Médecine, INSERM U-781, AP-HP, Hôpital Necker-Enfant Malades, Paris, France

Search for more papers by this author
M. Clement-Ziza

M. Clement-Ziza

Université Paris-René Descartes, Faculté de Médecine, INSERM U-781, AP-HP, Hôpital Necker-Enfant Malades, Paris, France

Search for more papers by this author
D. Trochet

D. Trochet

Université Paris-René Descartes, Faculté de Médecine, INSERM U-781, AP-HP, Hôpital Necker-Enfant Malades, Paris, France

Search for more papers by this author
S.E. Antonarakis

S.E. Antonarakis

Department of Genetic Medicine and Development, University of Geneva Medical School and University Hospitals of Geneva, Geneva, Switzerland

Search for more papers by this author
T. Attie-Bitach

T. Attie-Bitach

Université Paris-René Descartes, Faculté de Médecine, INSERM U-781, AP-HP, Hôpital Necker-Enfant Malades, Paris, France

Search for more papers by this author
P.L. Beales

P.L. Beales

Molecular Medicine Unit, Institute of Child Health, University College London, London, United Kingdom

Search for more papers by this author
J.-L. Blouin

J.-L. Blouin

Department of Genetic Medicine and Development, University of Geneva Medical School and University Hospitals of Geneva, Geneva, Switzerland

Search for more papers by this author
F. Dastot-Le Moal

F. Dastot-Le Moal

INSERM U-654, Bases Moléculaires et Cellulaires des Maladies Génétiques, Créteil, France

Search for more papers by this author
H. Dollfus

H. Dollfus

Service de Génétique Médicale, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

Search for more papers by this author
M. Goossens

M. Goossens

INSERM U-654, Bases Moléculaires et Cellulaires des Maladies Génétiques, Créteil, France

Search for more papers by this author
N. Katsanis

N. Katsanis

McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

Search for more papers by this author
R. Touraine

R. Touraine

Service de Génétique, Hôpital Nord, CHU Saint-Etienne, Saint-Etienne, France

Search for more papers by this author
J. Feingold

J. Feingold

Université Paris-René Descartes, Faculté de Médecine, INSERM U-781, AP-HP, Hôpital Necker-Enfant Malades, Paris, France

Search for more papers by this author
A. Munnich

A. Munnich

Université Paris-René Descartes, Faculté de Médecine, INSERM U-781, AP-HP, Hôpital Necker-Enfant Malades, Paris, France

Search for more papers by this author
S. Lyonnet

S. Lyonnet

Université Paris-René Descartes, Faculté de Médecine, INSERM U-781, AP-HP, Hôpital Necker-Enfant Malades, Paris, France

Search for more papers by this author
J. Amiel

Corresponding Author

J. Amiel

Université Paris-René Descartes, Faculté de Médecine, INSERM U-781, AP-HP, Hôpital Necker-Enfant Malades, Paris, France

Département de Génétique, Hôpital Necker-Enfants Malades, 149, rue de Sèvres, 75743 Paris Cedex 15, FranceSearch for more papers by this author
First published: 30 March 2007
Citations: 69

Communicated by Daniel Schorderet

Abstract

Hirschsprung disease (HSCR) stands as a model for genetic dissection of complex diseases. In this model, a major gene, RET, is involved in most if not all cases of isolated (i.e., nonsyndromic) HSCR, in conjunction with other autosomal susceptibility loci under a multiplicative model. HSCR susceptibility alleles can harbor either heterozygous coding sequence mutations or, more frequently, a polymorphism within intron 1, leading to a hypomorphic RET allele. On the other hand, about 30% of HSCR are syndromic. Hitherto, the disease causing gene has been identified for eight Mendelian syndromes with HSCR: congenital central hypoventilation (CCHS), Mowat-Wilson (MWS), Bardet-Biedl (BBS), Shah-Waardenburg (WS4), cartilage-hair-hypoplasia (CHH), Smith-Lemli-Opitz (SLO), Goldberg-Sprintzsen (GSS), and hydrocephalus due to congenital stenosis of the aqueduct of sylvius (HSAS). According to the HSCR syndrome, the penetrance of HSCR trait varies from 5 to 70%. Trisomy 21 (T21) also predisposes to HSCR. We were able to collect a series of 393 patients affected by CCHS (n = 173), WS4 (n = 24), BBS (n = 51), MWS (n = 71), T21 (n = 46), and mental retardation (MR) with HSCR (n = 28). For each syndrome, we studied the RET locus in two subgroups of patients; i.e., with or without HSCR. We genotyped the RET locus in 393 patients among whom 195 had HSCR, and compared the distribution of alleles and genotypes within the two groups for each syndrome. RET acts as a modifier gene for the HSCR phenotype in patients with CCHS, BBS, and Down syndrome, but not in patients with MWS and WS4. The frequent, low penetrant, predisposing allele of the RET gene can be regarded as a risk factor for the HSCR phenotype in CCHS, BBS, and Down syndrome, while its role is not significant in MWS and WS4. These data highlight the pivotal role of the RET gene in both isolated and syndromic HSCR. Hum Mutat 28(8), 790–796, 2007. © 2007 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.